UT Southwestern develops nanotherapeutic to ward off liver cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/nanotherapeutic-to-ward-off-liver-cancer.html?fbclid=IwAR0BcDOWp2UKETuoDkae2IlTo3yQAJ0QALlP2trZNCiZweKoRKBNOeGYBmk
Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver.
UT Southwestern nearly doubles lifespan of mice with brain cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/brain-cancer.html?utm_source=SCCC+Updates+Master+Distribution+List&utm_campaign=e1b4880a1d-EMAIL_CAMPAIGN_2020_02_14_02_00&utm_medium=email&u
UT Southwestern Simmons Cancer Center researchers have developed technology that is spawning a much better form of drug delivery for gene therapy and has achieved a 43 percent increase in the survival of mice with glioblastoma, one of the deadliest forms of human brain cancer.
Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/stereotactic-radiation-extends-systemic-therapy.html?fbclid=IwAR1nJaYKEYszHNEC8pwRgLaWmvicsg9TfaXSGeHYzFW8nJWsvZ4SctcKXnw
A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center shows that highly focused radiation to isolated metastases that progress despite drug therapy can prolong drug use in kidney cancer patients, saving the few other drugs for treating